7
Participants
Start Date
February 28, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
December 31, 2015
I-124-CLR1404
single-dose, intravenous
Hospital of University of Pennsylvania, Philadelphia
University of Maryland School of Medicine, Baltimore
Moffitt Cancer Center and Research Institute, Tampa
Ohio State University Medical Center, Columbus
Cleveland Clinic, Cleveland
Kettering Medical Center, Kettering
Medical College of Wisconsin, Milwaukee
University of Wisconsin, Madison
City of Hope, Duarte
Lead Sponsor
Cellectar Biosciences, Inc.
INDUSTRY